gallbladder and biliary system. They help with issues including acid reflux, irritable bowel syndrome, trouble with swallowing, gallstones, polyps and gastrointestinal cancers. For more information or ...
The FDA has approved a new drug, zanidatamab, for adults with advanced biliary tract cancer, or BTC. Marketed under the brand name Ziihera, it is a first-of-a-kind treatment for patients with ...
They’re also known as sunspots, solar lentigines, or liver spots — even though they have nothing to do with your liver. They are caused by long-term ultraviolet (UV) light exposure from both ...
Ipsen presents three late-breaking presentations and eight abstracts across rare cholestatic liver disease portfolio at AASLD 2024Elafibranor was granted marketing authorisation for the treatment of ...
Ipsen presents 3 late-breaking presentations and 8 abstracts across rare cholestatic liver disease portfolio at AASLD 2024Iqirvo approved for use in the U.S. in June 2024, in the E.U. in September 202 ...